Abstract
Purpose Purpose of this prospective, multi-institutional Phase I clinical study was to investigate whether MRI-guided transurethral ultrasound ablation (MR-TULSA), a novel minimally-invasive technology to treat organ-confined prostate cancer (PCa), is safe, feasible and effective. It employs directional plane-wave high-intensity ultrasound, which ablates prostate tissue using real-time thermometry with active temperature feedback control.
Highlights
Localised prostate cancer treated with MRIguided transurethral ultrasound ablation: phase I trial results
From International Cancer Imaging Society (ICIS) 14th Annual Teaching Course Heidelberg, Germany. 9-11 October 2014. Purpose of this prospective, multi-institutional Phase I clinical study was to investigate whether MRI-guided transurethral ultrasound ablation (MR-TULSA), a novel minimally-invasive technology to treat organ-confined prostate cancer (PCa), is safe, feasible and effective
Whole-gland prostate ablation was performed with MR-TULSA using the PAD-105 (Profound Medical Inc., Canada) and a 3T MRI (Siemens, Germany) in one single treatment session under general anaesthesia and 3D active MR-thermometry feedback control
Summary
Localised prostate cancer treated with MRIguided transurethral ultrasound ablation: phase I trial results. MB Wolf1*, M Roethke, S Pahernik, B Hadaschik, T Kuru, IV Popeneciu, G Hatiboglu, J Chin, M Billia, J Relle, J Hafron, K Nandalur, M Burtnyk, HP Schlemmer. From International Cancer Imaging Society (ICIS) 14th Annual Teaching Course Heidelberg, Germany. Purpose Purpose of this prospective, multi-institutional Phase I clinical study was to investigate whether MRI-guided transurethral ultrasound ablation (MR-TULSA), a novel minimally-invasive technology to treat organ-confined prostate cancer (PCa), is safe, feasible and effective. It employs directional plane-wave high-intensity ultrasound, which ablates prostate tissue using real-time thermometry with active temperature feedback control
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
